Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Versatile immunomagnetic nanocarrier platform for capturing cancer cells.

Wu CH, Huang YY, Chen P, Hoshino K, Liu H, Frenkel EP, Zhang JX, Sokolov KV.

ACS Nano. 2013 Oct 22;7(10):8816-23. doi: 10.1021/nn403281e. Epub 2013 Sep 12.

2.

Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.

Gorges TM, Tinhofer I, Drosch M, Röse L, Zollner TM, Krahn T, von Ahsen O.

BMC Cancer. 2012 May 16;12:178. doi: 10.1186/1471-2407-12-178.

3.

Molecular biomarker analyses using circulating tumor cells.

Punnoose EA, Atwal SK, Spoerke JM, Savage H, Pandita A, Yeh RF, Pirzkall A, Fine BM, Amler LC, Chen DS, Lackner MR.

PLoS One. 2010 Sep 8;5(9):e12517. doi: 10.1371/journal.pone.0012517.

4.

Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.

Watanabe M, Uehara Y, Yamashita N, Fujimura Y, Nishio K, Sawada T, Takeda K, Koizumi F, Koh Y.

Cytometry A. 2014 Mar;85(3):206-13. doi: 10.1002/cyto.a.22422. Epub 2013 Dec 10.

5.
6.

Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics.

Chen W, Allen SG, Reka AK, Qian W, Han S, Zhao J, Bao L, Keshamouni VG, Merajver SD, Fu J.

BMC Cancer. 2016 Aug 8;16:614. doi: 10.1186/s12885-016-2638-x.

7.

Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.

Königsberg R, Obermayr E, Bises G, Pfeiler G, Gneist M, Wrba F, de Santis M, Zeillinger R, Hudec M, Dittrich C.

Acta Oncol. 2011 Jun;50(5):700-10. doi: 10.3109/0284186X.2010.549151. Epub 2011 Jan 24.

PMID:
21261508
8.

Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients.

Liu Z, Fusi A, Klopocki E, Schmittel A, Tinhofer I, Nonnenmacher A, Keilholz U.

J Transl Med. 2011 May 19;9:70. doi: 10.1186/1479-5876-9-70.

9.

Quick-response magnetic nanospheres for rapid, efficient capture and sensitive detection of circulating tumor cells.

Wen CY, Wu LL, Zhang ZL, Liu YL, Wei SZ, Hu J, Tang M, Sun EZ, Gong YP, Yu J, Pang DW.

ACS Nano. 2014 Jan 28;8(1):941-9. doi: 10.1021/nn405744f. Epub 2013 Dec 13.

PMID:
24313365
10.

[Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].

Cai QQ, Huang HQ, Lin TX, Jiang WQ.

Ai Zheng. 2005 Jul;24(7):837-41. Chinese.

PMID:
16004811
11.

A novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of rare tumor cells in blood.

Watanabe M, Serizawa M, Sawada T, Takeda K, Takahashi T, Yamamoto N, Koizumi F, Koh Y.

J Transl Med. 2014 May 23;12:143. doi: 10.1186/1479-5876-12-143.

12.

Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor.

Adams AA, Okagbare PI, Feng J, Hupert ML, Patterson D, Göttert J, McCarley RL, Nikitopoulos D, Murphy MC, Soper SA.

J Am Chem Soc. 2008 Jul 9;130(27):8633-41. doi: 10.1021/ja8015022. Epub 2008 Jun 17.

13.

A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells.

Kang JH, Krause S, Tobin H, Mammoto A, Kanapathipillai M, Ingber DE.

Lab Chip. 2012 Jun 21;12(12):2175-81. doi: 10.1039/c2lc40072c. Epub 2012 Mar 28.

PMID:
22453808
14.

A novel microchannel-based device to capture and analyze circulating tumor cells (CTCs) of breast cancer.

Riahi R, Gogoi P, Sepehri S, Zhou Y, Handique K, Godsey J, Wang Y.

Int J Oncol. 2014 Jun;44(6):1870-8. doi: 10.3892/ijo.2014.2353. Epub 2014 Mar 21.

15.

Sensitive antibody-based CTCs detection from peripheral blood.

Shahneh FZ.

Hum Antibodies. 2013;22(1-2):51-4. doi: 10.3233/HAB-130270. Review.

PMID:
24284308
16.

Microfluidics and circulating tumor cells.

Dong Y, Skelley AM, Merdek KD, Sprott KM, Jiang C, Pierceall WE, Lin J, Stocum M, Carney WP, Smirnov DA.

J Mol Diagn. 2013 Mar;15(2):149-57. doi: 10.1016/j.jmoldx.2012.09.004. Epub 2012 Dec 22. Review.

17.

Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.

Mostert B, Kraan J, Bolt-de Vries J, van der Spoel P, Sieuwerts AM, Schutte M, Timmermans AM, Foekens R, Martens JW, Gratama JW, Foekens JA, Sleijfer S.

Breast Cancer Res Treat. 2011 May;127(1):33-41. doi: 10.1007/s10549-010-0879-y. Epub 2010 Apr 9.

PMID:
20379845
18.

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.

Kallergi G, Papadaki MA, Politaki E, Mavroudis D, Georgoulias V, Agelaki S.

Breast Cancer Res. 2011 Jun 10;13(3):R59. doi: 10.1186/bcr2896.

19.

Biomarkers characterization of circulating tumour cells in breast cancer patients.

Nadal R, Fernandez A, Sanchez-Rovira P, Salido M, Rodríguez M, García-Puche JL, Macià M, Corominas JM, Delgado-Rodriguez M, Gonzalez L, Albanell J, Fernández M, Solé F, Lorente JA, Serrano MJ.

Breast Cancer Res. 2012 May 3;14(3):R71.

20.

Enumeration, characterization, and collection of intact circulating tumor cells by cross contamination-free flow cytometry.

Takao M, Takeda K.

Cytometry A. 2011 Feb;79(2):107-17. doi: 10.1002/cyto.a.21014. Epub 2011 Jan 18.

Items per page

Supplemental Content

Write to the Help Desk